Background Chronic disease patients often face multiple challenges from difficult
comorbidities. Smartphone health technology can be used to help them manage their …

Cancer survivorship care and research has typically focused on the health care needs of
people with cancer following the acute phase of treatment. Work in this area, however, has …

Purpose Suboptimal adherence to tyrosine kinase inhibitors (TKIs) contributes to poor
clinical outcomes in chronic myeloid leukemia (CML). This randomised controlled trial (RCT) …

Background: Optimal dosing of oral tyrosine kinase inhibitor therapy is critical to treatment
success and survival of patients with chronic myeloid leukemia (CML). Drug intolerance …

Some believe that tyrosine kinase inhibitor (TKI) therapy is as close to perfect as it gets in
oncologic therapy. Patients diagnosed with chronic myeloid leukemia (CML) are treated with …

Introduction: Bone metastasis is seen in 2. 3–12. 7% of thyroid follicular carcinomas. Bone
metastasis most commonly occurs in the vertebrae, costas and hip bones. In this report we …

Oral therapies have become a common treatment choice for several lymphoid cancers.
While therapeutic efficacy and patient preference for this therapy type have been reported …

Introduction: The treatment of chronic phase chronic myeloid leukemia (CML) has changed
dramatically within the last two decades with the emergence of tyrosine kinase inhibitors …

Dear Editor, Tyrosine kinase inhibitors (TKI) are the drug of first choice for patients with
chronic myeloid leukaemia (CML)[1]. However, for achieving complete mole cular response …